Super-T002

N/A

Report date: 2024/11/13 15:29:24

Base Information

Drug NameSuper-T002
Drug Alias NameSuper-T002
ClassificationBiologics
Mechanisms of ActionComplement receptor type 2 modulatorsT-cell receptor antagonists
TargetsComplement receptor type 2T-cell receptor
Therapy Area/IndicationsNasopharyngeal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiosyngen Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiosyngen Pte Ltd
Inactive CompaniesN/A
Active IndicationsNasopharyngeal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A